Cowen and Company’s Incyte INCY Stock Holding History

Cowen and Company’s Portfolio INCY Stock Details INCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-20,900	Closed	-$60K	–	704
2021 Q3	$60K	Buy	+20,900	New	+$1.59M	﹤0.01%	370

Other funds holding INCY

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cowen and Company's INCY Position: Q4 2021 in Review

Cowen and Company sold out of Incyte (INCY) in Q4 2021, closing a stake of 3,579 shares — an estimated $246K sold.

Cowen and Company first reported a position in INCY in Q3 2021 and held it in 1 quarter. The position peaked at $246K in Q3 2021. 526 funds tracked by Wall St. Rank hold INCY as of Q4 2021.

Cowen and Company reported no remaining Incyte position as of Q4 2021 after selling out during the quarter.
Cowen and Company sold 3,579 Incyte shares in Q4 2021, an estimated $246K.
Cowen and Company first reported a position in Incyte in Q3 2021 and held it in 1 quarter.
Cowen and Company's Incyte position peaked at $246K in Q3 2021.
526 funds tracked by Wall St. Rank held Incyte as of Q4 2021.

Based on Cowen and Company's 13F filing for Q4 2021, filed 14 Feb 2022.